Exelixis
EXEL
#1694
Rank
โ‚น835.42 B
Marketcap
โ‚น2,925
Share price
0.70%
Change (1 day)
67.74%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚น835.42 Billion

As of November 2024 Exelixis has a market cap of โ‚น835.42 Billion. This makes Exelixis the world's 1694th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น835.42 B34.52%
2023โ‚น621.05 B45.06%
2022โ‚น428.13 B-0.55%
2021โ‚น430.49 B-5.46%
2020โ‚น455.37 B19.28%
2019โ‚น381.78 B-7.43%
2018โ‚น412.44 B-28.18%
2017โ‚น574.27 B95.49%
2016โ‚น293.75 B243.81%
2015โ‚น85.44 B377.9%
2014โ‚น17.87 B-74.42%
2013โ‚น69.88 B52.04%
2012โ‚น45.96 B35.37%
2011โ‚น33.95 B-15.54%
2010โ‚น40.20 B8.94%
2009โ‚น36.90 B44.84%
2008โ‚น25.47 B-28.18%
2007โ‚น35.47 B-7.28%
2006โ‚น38.26 B8.22%
2005โ‚น35.35 B14.59%
2004โ‚น30.85 B34.83%
2003โ‚น22.88 B0.45%
2002โ‚น22.78 B-49.4%
2001โ‚น45.02 B41.16%
2000โ‚น31.89 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Exelixis was reported to be:

โ‚น835.42 Billion
by Nasdaq info icon info icon
โ‚น835.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น5.744 T 587.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น10.227 T 1,124.18%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น20.810 T 2,390.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.910 T 1,086.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.064 T 1,463.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.122 T 3,625.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.932 T 1,328.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.64 B-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น44.02 B-94.73%๐Ÿ‡บ๐Ÿ‡ธ USA